grantGrants.gov

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

Organization National Institutes of HealthPosted 28 Oct 2024Deadline 7 Jan 2028
HHS-NIH1193.85393.866synopsis
Sign up free to applyFree account · Full description · Apply link · All opportunity types

Full Description

Opportunity Number: PAR-25-024 Document Type: synopsis CFDA Numbers: 93.853, 93.866

Read the full description

Sign up freeFree account · No credit card required
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) — National Institutes of Health | Dev Procure